WebWire | News by Industry : Medical / Pharmaceuticals

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients

Fri, 12 Jun 2026 10:38:47 EDT

• Expanded U.S. availability paired with new patient lifestyle quiz encourages informed decision-making ahead of cataract surgery. - • Cataracts are one of the leading causes of vision impairment.1 Nearly 20% of Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet only 5% have had cataract surgery.2 - • Over half a million eyes worldwide have already experienced clearer, extended range of vision with TECNIS PureSee IOL after cataract surgery.3,4 - • 9...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356176

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Wed, 10 Jun 2026 18:17:01 EDT

Sanofi today announced that the riliprubart MOBILIZE phase 3 study (clinical study identifier: NCT06290128) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) refractory to standard-of-care treatment will be stopped. This decision follows an interim analysis by an independent data monitoring committee, which determined that the MOBILIZE study is unlikely to provide sufficient efficacy. No safety signals related to riliprubart were identified as part of this interim a...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356074

Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO - May 2026

Wed, 10 Jun 2026 09:20:39 EDT

At the mid-way point of Immunization Agenda 2030 (IA2030), countries gathering at the Seventy-ninth World Health Assembly (WHA79) marked an important moment in reaffirming their commitment to reaching everyone, everywhere with life-saving vaccines. - - Member States and global health partners strongly reasserted their support for the strategy, goals, and programmatic implementation of IA2030, recognizing immunization as one of the most powerful, cost-effective and equitable health interv...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356034

AMA adopts new policies to improve affordable access to obesity treatments

Tue, 9 Jun 2026 09:02:36 EDT

Physicians and medical students convened for the Annual Meeting of the American Medical Association's (AMA) House of Delegates today and adopted new policies aimed at improving patient access to evidence-based obesity treatments while advancing broader efforts to address prescription drug affordability and insurance coverage barriers. - - The new policies build upon longstanding AMA policy supporting affordable access to prescription medications, prescription drug price transparency, pharma...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355989

3D-printed devices could streamline the production of drug-delivery microparticles

Tue, 9 Jun 2026 08:39:59 EDT

MIT researchers have demonstrated a low-cost design of specialized electronic nozzles, called triaxial electrospray emitters, that could be used to manufacture time-release drug-delivery particles or self-healing materials efficiently and at scale. - - Triaxial electrospray emitters use electricity to precisely dispense three liquids from microscopic nozzles to generate a steady stream with three distinct fluid layers. The liquid forms multilayered droplets, which can solidify into layered...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355980

Wiley Launches Advanced Brain to Push Disciplinary Boundaries Across Neuroscience & Related Fields

Tue, 9 Jun 2026 08:08:00 EDT

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of Advanced Brain, an open access, interdisciplinary journal dedicated to publishing cutting-edge research across neuroscience, neurology, psychiatry and psychology. The new journal, part of Wiley's Advanced Portfolio of high-impact collaborative journals, is now open for submissions. - - Advanced Brain is designed to further both fundamental and applied understanding of the...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355967

Sanofi's Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Mon, 8 Jun 2026 10:37:39 EDT

Sanofi's Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector - - - • Sarclisa administered via the CirCLIQ ® OBI offers a treatment experience designed around the needs of patients and HCPs and enables flexible administration in either home or outpatient settings - • Sarclisa is the first anticancer treatment to be administered through an OBI and the first MM treatment available by both SC OBI and manual injection in the EU - •...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355917

Thrifty Food Plan Costs Vary Widely Across US Regions and Cities

Mon, 8 Jun 2026 09:58:55 EDT

A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined how the cost of the USDA's Thrifty Food Plan (TFP), which serves as the basis for determining maximum SNAP benefits, varied across geographic regions, metropolitan areas, and seasons from 2012 to 2018. Researchers found that where a household is located plays a much larger role in the cost of a healthy diet than year-to-year inflation. - - Researchers used USDA Food-at-Home Monthl...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355898

Can taking aspirin uncover asymptomatic bladder cancer?

Fri, 5 Jun 2026 09:21:01 EDT

The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract. Results from a study in the Journal of Internal Medicine suggest that this may prompt a clinician to run tests that uncover an asymptomatic bladder tumor. - - For the study, investigators analyzed information on 50,771 Danish adults who started taking aspirin in 2005–2...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355816

GEODIS to enhance its pharmaceutical logistics capabilities and move into a new temperature controlled, GDP compliant warehouse in Manchester

Thu, 4 Jun 2026 10:28:06 EDT

GEODIS, a world leader in transport and logistics, announces the opening of a temperature-controlled GDP-compliant pharmaceutical warehouse close to the airport in Manchester designed to support both inventory management and cross-docking operations, reinforcing its capabilities in the fast-growing Pharma & Healthcare sector in the UK and Ireland. The facility is scheduled to go live on June 1st, 2026. - - The warehouse will offer 2,000 pallet positions and has been developed to accommodate...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355773

Sanofi launches 2026 global employee stock purchase plan

Thu, 4 Jun 2026 10:25:32 EDT

Sanofi's global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company's growth and results. In 2025 alone, more than 31,000 Sanofi employees - 44% of the total workforce, chose to invest in the company through the program. Today, nearly 90,000 current or former Sanofi employees are shareholders, a...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355771

Kaiser Permanente names Emily Holliman president of Mid-Atlantic States region

Wed, 3 Jun 2026 10:07:22 EDT

Kaiser Permanente has appointed Emily Holliman as president of Kaiser Permanente in the Mid-Atlantic States, effective immediately. Holliman has served as the region's interim president since June 2025, leading efforts to provide high-quality, integrated health care and coverage to the organization's 750,551 members across 35 medical centers in Maryland, Virginia, and Washington, D.C. - - A proven health care leader with more than 20 years of experience, Holiman brings deep experience in...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355699

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Wed, 3 Jun 2026 10:03:16 EDT

� Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease while preserving immune function - - � Results demonstrated significant reduction of systemic lupus erythematosus disease activity which continued beyond the 24-week primary endpoint, and were sustained through Week 52 in the nipocalimab 15 mg/kg group a - - � ...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355698

FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

Tue, 2 Jun 2026 10:54:17 EDT

The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge. - - When finalized, the guidance will outline how sponsors can use publicly available information and established platform knowledge, including chemistry, manufacturing and controls (CMC) data, nonclinical study results and clinical information, to streamline regulatory...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355643

Study Links Cannabis and Tobacco Co-Use to Lower Brain Performance in At-Risk Adolescents

Tue, 2 Jun 2026 10:50:35 EDT

New research shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls. The novel study appearing in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, fills a critical gap in research, providing clinicians and scientists with vital new insights into the risks associated with cannabis and tobacco co-use and the potential impact on vulnerable a...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355642

AMA statement on EO directing CDC to assess childhood vaccine schedule

Mon, 1 Jun 2026 12:15:33 EDT

Statement attributable to: - Bobby Mukkamala, MD - President, American Medical Association - - “There is no credible scientific evidence to support changing the current childhood vaccine schedule. That schedule is built on decades of rigorous research and real-world data, and it is designed to protect children in the U.S. when they are most vulnerable based on our nation's disease burden. - - “Altering it without clear, evidence-based justification risks continued confusion for parents and...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355567

WHO launches new guide to help scale psychological self-help

Mon, 1 Jun 2026 12:00:08 EDT

Psychological self-help interventions: delivering self-help for individuals, featuring Step-by-Step and Doing What Matters in Times of Stress provides practical advice on planning, adapting and delivering self-help, with or without support from trained non-specialists. More than one billion people worldwide live with a mental health condition, yet many lack access to effective care. Psychological self-help interventions are one way to help close this gap, offering structured techniques...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355562

Dr. Ashish Jha Headlines ConV2X Smart Technology Transformation Summit - NYC Oct 2026

Mon, 1 Jun 2026 08:00:00 EDT

Partners in Digital Health today announced that Dr. Ashish Jha, one of the most influential voices in modern healthcare policy and public health leadership, will headline ConV2X Smart Technology Transformation in Healthcare & Life Sciences, taking place October 29–30, 2026, at the Historic GE Building: ILR Conference Center in New York City. - - Dr. Jha serves as Senior Fellow at the Harvard Belfer Center and Co-Founder & CEO of BioRadar. He previously served as White House COVID-19 Respo...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355445

CONV2X Decentralized Health & Life Science Summit Releases FIRST SPEAKER COHORT

Mon, 1 Jun 2026 08:00:00 EDT

Partners in Digital Health is proud to announce the first speaker cohort for ConV2X Decentralized Health — a landmark gathering of innovators, clinicians, technologists, and policy leaders reimagining the future of healthcare through decentralized infrastructure. - - This inaugural cohort represents some of the most consequential voices at the intersection of blockchain, AI, digital health, and regulatory science: - - Ajaz Hussain — Former Deputy Director, Office of Pharmaceutical S

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355173

1 in 3 Women Don't Know Menopause and Bone Loss Are Connected, New Osteoboost Data Reveals

Thu, 28 May 2026 12:00:00 EDT

Osteoboost Health, the developer of the first and only FDA-cleared prescription medical device for low bone density, today released its inaugural State of Bones Report, designed to shine a light on the perspectives and experiences of women and their bone health as they enter the perimenopause-menopause transition and beyond. - - The report is based on an independent surv

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355386

Disney and Philips Bring Beloved Storytelling and Innovative Technology to Support Kids Undergoing MRI Exams

Thu, 28 May 2026 11:43:22 EDT

The Walt Disney Company and Philips today announced that beloved Disney animated characters and stories are being incorporated directly into Philips Ambient Experience for MRI at medical facilities in 87 countries worldwide. For many children, this type of immersive environment can help shift attention away from the clinical setting, creating a more comforting and engaging experience during scans and helping more children complete their exams successfully. - - “At Disney, we believe storie...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355439

Scars of Life: Study Shows Impact of Atopic Dermatitis on Educational and Career Choices

Thu, 28 May 2026 11:32:40 EDT

Atopic dermatitis (AD), the most common form of eczema, impacts patients' life trajectories beyond the physical scars. A novel study shows that adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than 36% reporting constrained study choices, compared to individuals whose disease began in adulthood. The findings of t...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355435

Sanofi's venglustat accepted for priority review in the US to treat type 3 Gaucher disease

Thu, 28 May 2026 09:37:11 EDT

The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder. - - If approved, venglustat would become the first treatment available in the US to address the progressive neurological manifestations associated with GD3 and expand Sanofi's portfolio of treatment options for pati...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355412

MindMaze Therapeutics Chooses Connect Labs by Wexford at Charlotte's The Pearl Innovation District for U.S. Headquarters to Advance Neurological Care

Thu, 28 May 2026 09:00:00 EDT

MindMaze Therapeutics, a pioneer in precision neurotherapeutics, has announced a U.S headquarters at The Pearl, Charlotte's Innovation District, a partnership between Atrium Health and Wexford Science & Technology, LLC. MindMaze has built a patient experience lab within Connect Labs by Wexford, a flexible, scale-in-place lab and innovation infrastructure that facilitates frictionless entry into the Charlotte innovation ecosystem. The neurotherapy company joins world-class companies a...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355378

Wiley Bolsters Research Integrity Efforts with Imagetwin's Enhanced Image Screening

Tue, 26 May 2026 10:00:47 EDT

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced that it has integrated Imagetwin's leading AI-powered image integrity software into Research Exchange, its award-winning research publishing platform. The integration adds sophisticated AI-powered image detection to the 25+ research integrity checks already embedded in Research Exchange, enabling editors and integrity...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355273

Shofu, Tosoh, Mitsui Chemicals, and Orbray Launch Joint Project to Recycle Zirconia Dental Waste

Fri, 22 May 2026 12:20:28 EDT

Shofu Inc. (headquartered in Kyoto, Kyoto Prefecture; Tetsuo Takami, Representative Director, President & COO); Tosoh Corporation (headquartered in Chuo-ku, Tokyo; Mamoru Kuwada, president and representative director); Mitsui Chemicals, Inc. (headquartered in Chuo-ku, Tokyo; Satoshi Ichimura, President and CEO); and Orbray Co., Ltd. (headquartered in Adachi-ku, Tokyo; Riyako Namiki, President and CEO) today are announcing the launch of a joint verification project to recycle zirconia waste...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355100

EBOLA OUTBREAK: "Unless a collective effort is made, this crisis is going to get worse"

Fri, 22 May 2026 12:08:10 EDT

Save the Children is rushing to contain an Ebola outbreak in the Democratic Republic of Congo, where decimated healthcare systems are ill equipped to stop its spread. - - At least 500 suspected cases of Ebola, and 130 deaths, have been reported in the DRC since the new outbreak began in early May, according to the World Health Organization. - - As Save the Children prepares to launch a large-scale response to support local health systems and help Ebola-impacted families and children, the h...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355098

AMA on Ways and Means unanimously endorsing budget neutrality reform

Fri, 22 May 2026 10:59:04 EDT

Statement attributable to: - Bobby Mukkamala, MD - President, American Medical Association - - “Physicians are grateful that the House Ways and Means Committee took a major step in curing a flawed budget policy that results in physicians facing Medicare cuts every year. Without reform, the Medicare Physician Fee Schedule produces a year-end budget mashup that injects uncertainty in physician practices due to the requirement that the fee schedule remain budget neutral. These cuts threaten...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355096

Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension

Thu, 21 May 2026 12:11:34 EDT

AstraZeneca's Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood pressure in adults who are not adequately controlled. - - There are 1.4 billion people worldwide living with hypertension.1 In the US, approximately 50% of patients living with hypertension who are already taking multiple antihypertensive medications still struggle...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355026

AMA statement on HHS removing vice chairs of USPSTF

Thu, 21 May 2026 11:52:08 EDT

Statement attributable to: - Bobby Mukkamala, MD - President, American Medical Association - - “The AMA is extremely concerned by today's HHS decision to remove the vice-chairs of the U.S. Preventive Services Task Force (USPSTF). The task force serves an essential, non-partisan role in making evidence-based recommendations on clinical preventive services and screenings that physicians rely on to prevent disease. - - “Today's changes were foreshadowed by the earlier dismantling of the Advis...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355020

WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination

Thu, 21 May 2026 11:44:45 EDT

The World Health Organization (WHO) and Gilead Sciences have renewed their partnership through a new five-year agreement (2026–2030) to support the elimination of visceral leishmaniasis (VL), a life-threatening neglected tropical disease. - - Under the agreement, Gilead Sciences will donate 402 941 vials of AmBisome (liposomal amphotericin B for injection) to treat visceral leishmaniasis and its complications in countries most affected by the disease. Gilead Sciences started donating this m...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355018

Novel Mouse Model Mirrors Human Pathology of Geleophysic Dysplasia, Facilitating Research

Thu, 21 May 2026 11:08:02 EDT

Researchers have developed a novel mouse model that replicates severe geleophysic dysplasia, including short stature, heart valve alterations, and early lethality—characteristics of this rare disease. The findings from the study in The American Journal of Pathology, published by Elsevier, provide a basis for the identification of molecular mechanisms underlying geleophysic dysplasia, which can then be targeted for therapeutic purposes. - - Geleophysic dysplasia is a debilitating diseas...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=355007

New MRC investment supports clinical research careers in the UK

Wed, 20 May 2026 09:43:47 EDT

The investment will establish 10 Regional Accounts for Clinical Researchers (RACR), bringing together more than 50 research organisations and over 60 NHS organisations across England, Scotland, Wales and Northern Ireland. - - RACR is a pilot initiative supporting clinicians at critical stages in their research careers to stay involved in research alongside clinical practice. - - The initiative will strengthen the UK's clinical research workforce, which underpins innovation, improved care and...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354929

“Brain Signatures Whisper Warnings:” Researchers Identify Age 9 as Critical Turning Point for Anxiety and Depression

Tue, 19 May 2026 12:22:32 EDT

A longitudinal study tracking children over a period of seven years identified distinct brain-wave patterns emerging from age 9 can forecast a child's vulnerability to anxiety or depression by age 13. These predictive markers reveal divergent, hemisphere-specific neurodevelopmental trajectories. Anxiety is linked to activity on the right side of the brain, while depression is tied to the left. The findings from the novel study in Biological Psychiatry, published by Elsevier, provide a...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354895

UNICEF scaling up efforts to protect and support children and families following Ebola outbreaks in the Democratic Republic of the Congo and Uganda

Tue, 19 May 2026 12:05:35 EDT

“UNICEF is deeply concerned by confirmed Ebola outbreaks in the Democratic Republic of the Congo (DRC) and Uganda, and the growing risk to children and vulnerable communities across the region – a situation the World Health Organization has now declared a Public Health Emergency of International Concern. - - “A total of 246 suspected cases have been reported so far, with 80 suspected deaths recorded in Ituri Province, eastern DRC, and Uganda has also reported two cases, with one death. The...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354890

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD

Tue, 19 May 2026 11:15:38 EDT

- - • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency - • Efdoralprin alfa is a recombinant protein distinct from plasma-derived therapy, which has been the standard-of-care for nearly 40 years - - - Data from the global ElevAATe phase 2 study (clinical study identifier: NCT05856331 ) demonstrated superiority of investigational efdoralprin alfa over standard-of-care therapy in achie...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354867

ConV2X 2026 Releases Preliminary Agenda for Cambridge Summit on Decentralized Health Systems

Mon, 18 May 2026 08:00:00 EDT

ConV2X has announced the preliminary agenda for its 2026 summit, outlining a three-day program focused on the structural transformation of healthcare systems through AI, decentralized infrastructure, data sovereignty, clinical intelligence, and regulatory modernization. - - Taking place September 23–25, 2026 at The Foundry in Cambridge, Massachusetts, ConV2X 2026 convenes leaders across healthcare, life sciences, AI, cybersecurity, blockchain infrastructure, and regulatory science to exami...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354801

Introducing Chromie Health: A Startup Developing AI Agents to Automate Hospital Staffing

Thu, 14 May 2026 12:02:10 EDT

Chromie Health, one of the world's fastest-growing AI-powered scheduling and management platform for hospital operations, today announced a $2 million pre-seed round led by AIX Ventures along with the launch of Chromie Dispatch, the company's flagship AI agent that instantly fills internal shift gaps via simple SMS. The funding comes amidst strong demand from 750 hospitals on the waitlist for the service and will fuel the company's development of a full suite of intelligent agents designe...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354669

Global study of clinicians by Elsevier finds nurses being left out of clinical AI adoption

Wed, 13 May 2026 16:09:16 EDT

Elsevier's Clinician of the Future 2026 report reveals emerging gaps in AI adoption, especially for clinician-specific solutions. In particular, nurses report feeling underrepresented both in AI use and in organizational decision-making around AI. - - Now in its fifth year, the global survey drew responses from 2,757 clinicians across 118 countries, including physicians and nurses. - - Main Report Key Findings: - - Survey respondents across geographies say they are stretched thin. While c...

Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=354664